186 related articles for article (PubMed ID: 29673523)
1. Anesthetic Drug Discovery and Development: A Case Study of Novel Etomidate Analogs.
McGrath M; Raines DE
Methods Enzymol; 2018; 603():153-169. PubMed ID: 29673523
[TBL] [Abstract][Full Text] [Related]
2. Analogues of etomidate: modifications around etomidate's chiral carbon and the impact on in vitro and in vivo pharmacology.
Pejo E; Santer P; Jeffrey S; Gallin H; Husain SS; Raines DE
Anesthesiology; 2014 Aug; 121(2):290-301. PubMed ID: 24777068
[TBL] [Abstract][Full Text] [Related]
3. Sedative-hypnotic Binding to 11β-hydroxylase.
Pejo E; Zhou X; Husain SS; Raines DE
Anesthesiology; 2016 Nov; 125(5):943-951. PubMed ID: 27541316
[TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro pharmacological studies of methoxycarbonyl-carboetomidate.
Pejo E; Cotten JF; Kelly EW; Le Ge R; Cuny GD; Laha JK; Liu J; Lin XJ; Raines DE
Anesth Analg; 2012 Aug; 115(2):297-304. PubMed ID: 21965364
[TBL] [Abstract][Full Text] [Related]
5. Methoxycarbonyl-etomidate: a novel rapidly metabolized and ultra-short-acting etomidate analogue that does not produce prolonged adrenocortical suppression.
Cotten JF; Husain SS; Forman SA; Miller KW; Kelly EW; Nguyen HH; Raines DE
Anesthesiology; 2009 Aug; 111(2):240-9. PubMed ID: 19625798
[TBL] [Abstract][Full Text] [Related]
6. Carboetomidate: a pyrrole analog of etomidate designed not to suppress adrenocortical function.
Cotten JF; Forman SA; Laha JK; Cuny GD; Husain SS; Miller KW; Nguyen HH; Kelly EW; Stewart D; Liu A; Raines DE
Anesthesiology; 2010 Mar; 112(3):637-44. PubMed ID: 20179500
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship of etomidate derivatives at the GABA(A) receptor: Comparison with binding to 11beta-hydroxylase.
Atucha E; Hammerschmidt F; Zolle I; Sieghart W; Berger ML
Bioorg Med Chem Lett; 2009 Aug; 19(15):4284-7. PubMed ID: 19497738
[TBL] [Abstract][Full Text] [Related]
8. A Novel Etomidate Analog EL-0052 Retains Potent Hypnotic Effect and Stable Hemodynamics without Suppressing Adrenocortical Function.
Xu X; Wei Y; Dong Y; Qiu Y; Mei Z; Wang K; Xiu J; Wang T; Zeng L; Dong X; Shen Y; Jiang W; Li Q
J Pharmacol Exp Ther; 2021 Dec; 379(3):324-330. PubMed ID: 34521699
[TBL] [Abstract][Full Text] [Related]
9. Dimethoxy-etomidate: A Nonhypnotic Etomidate Analog that Potently Inhibits Steroidogenesis.
McGrath M; Ma C; Raines DE
J Pharmacol Exp Ther; 2018 Feb; 364(2):229-237. PubMed ID: 29203576
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological studies of methoxycarbonyl etomidate's carboxylic acid metabolite.
Ge RL; Pejo E; Haburcak M; Husain SS; Forman SA; Raines DE
Anesth Analg; 2012 Aug; 115(2):305-8. PubMed ID: 22052979
[TBL] [Abstract][Full Text] [Related]
11. Behavioral and steroidogenic pharmacology of phenyl ring substituted etomidate analogs in rats.
McGrath M; Hofmann A; Raines DE
BMC Pharmacol Toxicol; 2019 Aug; 20(1):48. PubMed ID: 31383012
[TBL] [Abstract][Full Text] [Related]
12. Advancing novel anesthetics: pharmacodynamic and pharmacokinetic studies of cyclopropyl-methoxycarbonyl metomidate in dogs.
Campagna JA; Pojasek K; Grayzel D; Randle J; Raines DE
Anesthesiology; 2014 Dec; 121(6):1203-16. PubMed ID: 25170571
[TBL] [Abstract][Full Text] [Related]
13. Adrenocortical suppression and recovery after continuous hypnotic infusion: etomidate versus its soft analogue cyclopropyl-methoxycarbonyl metomidate.
Ge R; Pejo E; Cotten JF; Raines DE
Crit Care; 2013 Jan; 17(1):R20. PubMed ID: 23363638
[TBL] [Abstract][Full Text] [Related]
14. An Etomidate Analogue With Less Adrenocortical Suppression, Stable Hemodynamics, and Improved Behavioral Recovery in Rats.
Wang B; Yang J; Chen J; Kang Y; Yang LH; Liu J; Zhang WS
Anesth Analg; 2017 Aug; 125(2):442-450. PubMed ID: 28514325
[TBL] [Abstract][Full Text] [Related]
15. Closed-loop continuous infusions of etomidate and etomidate analogs in rats: a comparative study of dosing and the impact on adrenocortical function.
Cotten JF; Le Ge R; Banacos N; Pejo E; Husain SS; Williams JH; Raines DE
Anesthesiology; 2011 Oct; 115(4):764-73. PubMed ID: 21572317
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of etomidate and its pyrrole analogue carboetomidate on the adrenocortical and cytokine responses to endotoxemia.
Pejo E; Feng Y; Chao W; Cotten JF; Le Ge R; Raines DE
Crit Care Med; 2012 Jan; 40(1):187-92. PubMed ID: 21926608
[TBL] [Abstract][Full Text] [Related]
17. γ-Aminobutyric Acid Type A Receptor Modulation by Etomidate Analogs.
Pejo E; Santer P; Wang L; Dershwitz P; Husain SS; Raines DE
Anesthesiology; 2016 Mar; 124(3):651-63. PubMed ID: 26691905
[TBL] [Abstract][Full Text] [Related]
18. Contrasting Effects of the γ-Aminobutyric Acid Type A Receptor β3 Subunit N265M Mutation on Loss of Righting Reflexes Induced by Etomidate and the Novel Anesthetic Barbiturate R-mTFD-MPAB.
Amlong CA; Perkins MG; Houle TT; Miller KW; Pearce RA
Anesth Analg; 2016 Nov; 123(5):1241-1246. PubMed ID: 27331778
[TBL] [Abstract][Full Text] [Related]
19. Modifying methoxycarbonyl etomidate inter-ester spacer optimizes in vitro metabolic stability and in vivo hypnotic potency and duration of action.
Husain SS; Pejo E; Ge R; Raines DE
Anesthesiology; 2012 Nov; 117(5):1027-36. PubMed ID: 22929736
[TBL] [Abstract][Full Text] [Related]
20. Clinical and molecular pharmacology of etomidate.
Forman SA
Anesthesiology; 2011 Mar; 114(3):695-707. PubMed ID: 21263301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]